BREAKTHROUGH NEURAL THERAPIES
We explore emerging therapeutic strategies and advanced molecular approaches to bring scientific progress closer to real treatment options for neurological disorders.
Spinal Cord Injury
Where Neural Research Meets Real Impact
Neural Drug Research is an independent research group focused on evaluating emerging therapeutics for spinal cord injury. Our work bridges scientific rigor with clinical relevance to support evidence-based innovation.
Vision
To become a trusted reference centre for the scientific evaluation of neurological therapeutics and
to bridge the gap between academic research and clinical implementation.
Mission
- Conduct scientific assessments of novel spinal cord injury therapies
- Develop analytical tools and research frameworks
- Accelerate translation of scientific advances into clinical practice
Advancing neurological therapeutics through science
Scientific Insights & Research Updates
We curate and analyze recent research findings, therapeutic developments, and scientific insights to support informed progress in neurological treatment strategies.
Epidural Stimulation: Electrical Activation of Spinal Circuits After SCI
Epidural stimulation (ES) is an experimental neuromodulation approach in which a small array of elec...
Hypnosis: Exploring Its Role in Pain, Stress, and Neuropsychological Support
• Hypnosis is a psychological state characterized by focused attention, reduced peripheral awareness...
Thymosin β4 (TB-500): A Multifunctional Peptide in Neural and Tissue Repair
Thymosin β4 (Tβ4), also known in synthetic research form as TB-500, is a naturally occurring 43–amin...
Chondroitinase ABC (ChABC): Enzymatic Degradation of Inhibitory ECM After Spinal Cord Injury
Introduction
After spinal cord injury (SCI), the central nervous system responds with inflammatio...
Axonis Therapeutics: Advancing KCC2 Modulation for Neural Recovery
Introduction
Axonis Therapeutics is a biotechnology company developing first-in-class oral small-...
GHK-Cu: Exploring a Naturally Occurring Peptide in Tissue Repair and Wound Biology
Introduction
GHK-Cu is a naturally occurring peptide–copper complex found in human plasma, saliva, ...
KCL-286: A Selective RARβ Agonist for Neural Repair
Introduction
KCL-286 is an orally administered small-molecule drug being developed to support rep...
Pharmacologic and Cellular Approaches in Spinal Cord Injury: A Critical Overview
Article reviewed:
Khalid SI et al. Pharmacologic and cellular therapies in the treatment of traumat...
New Approaches to Modulating CSPG Signaling After Spinal Cord Injury
A recent wave of studies is taking a closer look at how chondroitin sulfate proteoglycans (CSPGs) co...
A Glimpse on NVG-291 History
40 Years of Dr. Jerry Silver’s Groundbreaking Research Now Reaches SCI Patients
Dr. Jerry Silver’...